Clay Sieagall Explores Quest to Reinvent Cancer Therapy

The field of cancer has seen hundreds of companies venture into research to find better ways of dealing with the menace. One of the most successful companies in this space is Seattle Genetics, which has been delivering cancer treatment solutions using modern and unique technology. As their CEO, Clay Siegall, cited during an interview with Endgadget, the company is looking to reinvent the way people receive cancer therapy and in less than five years, they will have a system that seamlessly deals with the many cancer problems people face. Over the past five years, the stock prices of Seattle Genetics tripled and the company is on an upward growth trajectory.

Clay Siegall has shown great passion and dedication in confronting the fight against cancer. He foresees a world where the lives of cancer patients will be improved through specialized care that can detect and completely eliminate the menace. As the CEO and President of Seattle Genetics, Clay Siegall has been inviting professionals from various companies to join in the research projects that are sponsored by Seattle Genetics. This partnership is meant to bring about a reinvention in the cancer research program that should lead to the development of reliable solutions for cancer patients.

With several drug pipelines, Seattle Genetics has also managed to enter into partnerships with some of the most established companies like GlaxoSmithKline. These partnerships have been a great asset to availing expert support and tools for cancer research projects and the success rate of these projects has been impressive all along.

About Clay B. Siegall, Ph.D.

Clay B. Siegall, a co-founder of Seattle Genetics, is the company’s CEO and President and he also chairs the Board. He is a clinical scientist by profession and when they founded the company in 1998, his ideas were to create a platform inspired by research and innovation. He has been guiding the research projects of the company and he is always careful about quality and offering useful products that support the delivery of strong and reliable solutions. Under his leadership, the company entered into several licenses for the ADC Technology they pioneered.Cancer Therapy

Leave a Reply